What question did this study set out to answer?

The research aims to evaluate changes in mortality and healthcare costs for chronic kidney disease within Brazil's Unified Health System from 2015 to 2024.

March 28, 2026Open Access

WCN26-5090 Evolution of Mortality and Expenditure in the Brazilian Unified Health System (SUS) in the Hospitalar Treatment of Chronic Kidney Disease between 2015 and 2024

Key Points

The research aims to evaluate changes in mortality and healthcare costs for chronic kidney disease within Brazil's Unified Health System from 2015 to 2024.
Analysis of healthcare expenditure data from 2015 to 2024
Assessment of mortality rates in chronic kidney disease patients
Comparative analysis of treatment regimens
Noted trends in decreased mortality rates for chronic kidney disease patients
Increased healthcare expenditure on hospital treatments
Emergence of the RCP regimen as a preferred treatment with fewer complications

Abstract

Conclusion:The RCP regimen offers a highly effective and safe alternative to the Modified Ponticelli Regimen for the treatment of idiopathic membranous nephropathy.It provides rapid and sustained remission with fewer adverse events and better tolerability.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

AIに質問

Bookmark

View Full Paper